Researchers Receive Grant to Improve Cellular Therapies to Treat ‘Incurable’ Diseases – University of Arkansas Newswire

Photo Submitted Left: Jorge Almodovar, Right: Raj Rao Two U of A researchers received a $480,000 National Science Foundation grant to investigate how engineered coatings that imitate the tissue matrixsurroundingcells would affect the behavior of therapeutic human mesenchymal stromal cells, or hMSCs. Jorge Almodovar, assistant professor of chemical engineering, and Raj Rao, professor and head of the Department of Biomedical Engineering, were awarded the grant from the NSF Division of Chemical, Bioengineering, Environmental, and Transport Systems. The grant will support research to explore how the extracellular matrix mimetic coatings affect the behavior of therapeutic hMSCs

Read more
Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform – Technology Networks

2021 marks the 20th anniversary of Lonzas groundbreaking Nucleofector Technology, the industrys leading non-viral cell transfection method, which has been cited more than 10,000 times, including in research by two Nobel Laureates. The innovative Nucleofector Technology enables the transfer of nucleic acids and proteins directly into the cells nuclei by combining optimized electrical parameters and cell type-specific solutions.

Read more
New consortium aims to accelerate development of stem cell-based therapies for Huntingtons disease – News-Medical.Net

The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's Disease. The entity, made up of twenty-eight renowned researchers from ten countries, has been officially presented in a recent publication in the Journal of Huntington's Disease

Read more
Real-time imaging shines light on the coordination of neural stem cell activation – News-Medical.net

In all adult vertebrates, neural stem cells can be recruited to produce new neurons in the brain. However, little is known about these so-called "activation" processes. Scientists at the Institut Pasteur, CNRS, and Tel Aviv University working in collaboration with the cole Polytechnique and INRAE have successfully performed 3D visualization and spatial and temporal distribution analysis of neural stem cell activation in the adult brain of a zebrafish vertebrate model

Read more
Searching for Molecular Targets in Myeloid Malignancies and Beyond – OncLive

Significant headway has been made in recent years to develop novel therapeutics that can eliminate entire mutant subclones in patients with myeloid malignancies, some of which include immunotherapy, dual MDMX and MDM2 inhibition, and STAT3 inhibition, according to Ulrich Steidl, MD, PhD. In lymphoid malignancies, we have very good immunotherapy targets, including CD19 and a few others. [However,] in myeloid malignancies, more specific targets have been lacking, Steidl said

Read more
Fitore Nutrition Launches Spectrum + to Better the Lives of Children With Autism – Influencive

Statistics reveal an alarming rate of increase in childhood diseases. Among them, Autism Spectrum Disorder (ASD) sits at the very top, beating the combined number of juvenile diabetes, childhood cancer, and childhood AIDs. Autism is so prevalent that one in every 68 American children is born with the disease, affecting not only the person with the illness but their whole families as well.

Read more
Cancer Stem Cells Market By Size Estimation, Growth Rate, Regional Analysis With with the CAGR of 11.0% Over the Forecast Period. KSU | The Sentinel…

The Cancer Stem Cells market report provides a detailed analysis of the emerging trends, opportunities, and as well as the challenges in the market. This extensive report sheds light on the latest developments, market drivers, and competitive analysis to help the new entrants and emerging players to make crucial decisions.

Read more